Sort
21,281 grants matching “influenza”
AZD9688: A First in Class Disease Modifying Therapy to Treat Alpha-1 Antitrypsin Deficiency a Genetically Linked Orphan Disease
$1,815,951Mark T Dransfield · University Of Alabama At Birmingham · UH3 · FY2019 · TR
T CELL MEMORY TO PATHOGENS: GENERATION AND FUNCTION
$1,815,757Trudeau Institute, Inc. · P01 · FY2004 · AI
Comparison of High vs. Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant Recipients
$1,815,533Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2023 · AI
T Cell Memory to Pathogens: Generation and Function
$1,813,970Susan L Swain · Univ Of Massachusetts Med Sch Worcester · P01 · FY2013 · AI
Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site
$1,813,428Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2022 · AI
Molecular structures of tau aggregates studied by solid-state NMR
$1,803,825Mei Hong · Massachusetts Institute Of Technology · RF1 · FY2018 · AG
Toward a Universal Influenza Virus Vaccine
$1,803,471Peter Palese · Icahn School Of Medicine At Mount Sinai · P01 · FY2020 · AI
Toward a Universal Influenza Virus Vaccine
$1,802,510Peter Palese · Icahn School Of Medicine At Mount Sinai · P01 · FY2018 · AI
Annual Estimates of Influenza Vaccine Effectiveness and Evaluation of Immune Response in a Wisconsin Population
$1,800,000Edward Belongia · Marshfield Clinic Research Foundation · U01 · FY2020 · IP
Prospective annual estimates of influenza vaccine effectiveness and burden of disease
$1,800,000Michael L Jackson · Kaiser Foundation Research Institute · U01 · FY2020 · IP
Mandatory_Estimates of Vaccine Effectiveness Against Medically-Attended, PCR-Confirmed Influenza in West South Central U.S.
$1,800,000Manjusha Gaglani · Scott And White Memorial Hospital · U01 · FY2020 · IP
Research on the Epidemiology, Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in Southeast Asia and the Western Pacific
$1,800,000Benjamin John Cowling · University Of Hong Kong · U01 · FY2017 · IP
US Influenza Vaccine Effectiveness Network
$1,799,999Arnold S Monto · University Of Michigan At Ann Arbor · U01 · FY2018 · IP
US Influenza Vaccine Effectiveness Network
$1,799,998Arnold S Monto · University Of Michigan At Ann Arbor · U01 · FY2019 · IP
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$1,796,843Richard Rothman · Johns Hopkins University · N01 · FY2019 · AI
Mechanisms and Intracellular Components in Exocytosis, Membrane Assembly and Repair, and Parasite Replication
$1,794,330Joshua Zimmerberg · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
HT-Film-Array: a system to assess respiratory viruses with emphasis on influenza
$1,793,553Steven F Dobrowolski · Biofire Defense, Llc. · U01 · FY2007 · AI
Direct and Indirect Protection by Influenza Vaccine Given to Children in India
$1,791,800Wayne M Sullender · University Of Alabama At Birmingham · U01 · FY2009 · IP
Toward a Universal Influenza Virus Vaccine
$1,790,702Peter Palese · Icahn School Of Medicine At Mount Sinai · P01 · FY2019 · AI
CFI Pathogen Inactivation of Human Plasma Units
$1,789,666Trevor P. Castor · Aphios Corporation · R44 · FY2020 · HL
Modulation of Biodefense Responses to Microbial Pathogens
$1,789,049Leo Lefrancois · University Of Connecticut Sch Of Med/Dnt · P01 · FY2010 · AI
Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort
$1,786,162Carlos A. Camargo · Massachusetts General Hospital · R01 · FY2017 · AI
Development of Fludase as an Anti-Influenza Agent
$1,785,659Mang Yu · Nexbio, Inc. · U01 · FY2008 · AI
Vaccine and Treatment Evaluation Unit at Saint Louis University
$1,780,596Daniel F. Hoft · Saint Louis University · UM1 · FY2022 · AI
Aging and Immunity to Infections
$1,777,452Trudeau Institute, Inc. · P01 · FY2003 · AG